Yunming Xu, Pharm.D.

Biopharmaceutics Reviewer
US Food and Drug Administration

Poster(s):

• (M1130-11-61) Development of Biorelevant Dissolution Methods for Potential Risk-Based Biowaivers of BCS Class IIa Compounds: Impact of pH, Buffer Capacity and Hydrodynamics of Dissolution Media
  Monday, October 21, 2024

  11:30 AM – 12:30 PM MT

• (T1530-02-07) Establishing a Dissolution Safe Space for Ibuprofen as a Model BCS Class IIa Drug Using Product Particle Size Distribution (P-PSD) Approaches to Support Biowaiver Consideration
  Tuesday, October 22, 2024

  3:30 PM – 4:30 PM MT